OVERVIEW OF DRUG TRANSPORTER FAMILIES - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 9

32. Ritzel MWL, Ng AML, Yao SYM, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles
DA, Carpenter P, Chen XZ, et al., 2001: Molecular identification and characterization of
novel human and mouse concentrative Na(+)-nucleoside cotransporter proteins (hCNT3
and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol
Chem 276: 2914-2927.
33. Coe IR, Griffiths M, Young JD, Baldwin SA, Cass CE, 1997: Assignment of the human
equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2. Genomics 45: 459-460.
34. Williams JB, Rexer B, Sirripurapu S, John S, Goldstein R, Phillips JA III, Haley LL, Sait
SNJ, Shows TB, Smith CM, Gerhard DS, 1997: The human HNP36 gene is localized to
chromosome 11q13 and produces alternative transcripts that are not mutated in multiple
endocrine neoplasia, type 1 (MEN I) syndrome. Genomics 42: 325-330.
35. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD, 2004: The equilibrative
nucleoside transporter family, SLC29. Pflugers Arch Feb;447(5): 735-743.
36. Engel K, Zhou M, Wang J, 2004: Identification and characterization of a novel monoamine
transporter in the human brain. J Biol Chem 279: 50042-50049.
37. Shiao T, Iwahashi M, Fortune J, Quattrochi L, Bowman S, Wick M, Qadri I, Simon
FR, 2000: Structural and functional characterization of liver cell-specific activity of the
human sodium/taurocholate cotransporter. Genomics 69: 203-213.
38. Wong MH, Rao PN, Pettenati MJ, Dawson PA, 1996: Localization of the ileal sodium-bile
acid cotransporter gene (SLC10A2) to human chromosome 13q33. Genomics 33: 538-540.
39. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan
K, Childs S, Ling V, et al., 1998: A gene encoding a liver-specific ABC transporter is
mutated in progressive familial intrahepatic cholestasis. Nat Genet Nov;20(3): 233-238.
40. Seward DJ, Koh AS, Boyer JL, Ballatori N, 2003: Functional complementation between
a novel mammalian polygenic transport complex and an evolutionarily ancient organic
solute transporter, OSTalpha-OSTbeta. J Biol Chem Jul 25;278(30): 27473-27482.
41. Trent JM, Witkowski CM,1987: Clarification of the chromosomal assignment of the
human P-glycoprotein/mdr1 gene: possible coincidence with the cystic fibrosis and c-met
oncogene. Cancer Genet Cytogenet May;26(1): 187-190.
42. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ,
Kurz EU, Duncan AMV, Deeley RG, 1992: Overexpression of a transporter gene in a
multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.
43. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K,
Okumura K, Akiyama S, Kuwano M, 1996: A human canalicular multispecific organic
anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell
lines with decreased drug accumulation. Cancer Res. 56: 4124-4129.
44. Uchiumi T, Hinoshita E, Haga S, Nakamura T, Tanaka T, Toh S, Furukawa M, Kawabe
T, Wada M, Kagotani K, et al., 1998: Isolation of a novel human canalicular multispecific
organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer
cells with decreased ATP-dependent drug transport. Biochem Biophys Res Commun 252:
103-110.
45. Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD, 1998: Isolation of MOAT-B, a widely
expressed multidrug resistance-associated protein/canalicular multispecific organic anion
transporter-related transporter. Cancer Res 58: 2741-2747.
46. Suzuki T, Nishio K, Sasaki H, Kurokawa H, Saito-Ohara F, Ikeuchi T, Tanabe S, Terada M,
Saijo N, 1997: cDNA cloning of a short type of multidrug resistance protein homologue,